Andrew J. M. Boulton, MD, describes the impact of non-invasive glucose monitoring devices on adherence and hospital admission rates.
Andrew J. M. Boulton, MD, describes the impact of non-invasive glucose monitoring devices on patient monitoring adherence and hospital admission rates and costs. Theoretically, patients using non-invasive glucose monitoring devices will better adhere to regular monitoring than with invasive devices; however, Dr. Boulton says that there is a need for controlled trials to provide evidence-based data to support this conclusion.
This video was taken on June 8, 2012, at the American Diabetes Association's 72nd Scientific Session in Philadelphia, PA.
Exploring Pharmaceutical Innovations, Trust, and Access With CVS Health's CMO
July 11th 2024On this episode of Managed Care Cast, we're talking with the chief medical officer of CVS Health about recent pharmaceutical innovations, patient-provider relationships, and strategies to reduce drug costs.
Listen